Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-GPCR-Histamine Receptor-ABT-288
ABT-288

Chemical Structure : ABT-288

CAS No.: 948845-91-8

ABT-288 (ABT288)

Catalog No.: PC-63032Not For Human Use, Lab Use Only.

ABT-288 is a potent, selective and competitive antagonist of H3 receptor with Ki of 1.9/8.2 nM for human/rat H3 respectively.

Packing Price Stock Quantity
5 mg $298 In stock
10 mg $478 In stock
25 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

ABT-288 is a potent, selective and competitive antagonist of H3 receptor with Ki of 1.9/8.2 nM for human/rat H3 respectively.
ABT-288 enhances the release of acetylcholine and dopamine in rat prefrontal cortex.
ABT-288 possesses excellent pharmacokinetics and oral bioavailability.

Physicochemical Properties

M.Wt 372.472
Formula C23H24N4O
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2-[4'-((3aR,6aR)-5-methyl-hexahydro-pyrrolo[3,4-b]pyrrol-1-yl)-biphenyl-4-yl]-2H-pyridazin-3-one

References

1. Esbenshade TA, et al. J Pharmacol Exp Ther. 2012 Oct;343(1):233-45.

2. Hudzik TJ, et al. Psychopharmacology (Berl). 2013 Jul;228(2):187-97.

3. Othman AA, et al. Br J Clin Pharmacol. 2014 Jun;77(6):965-74.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: